Reacción #1253194

ord-621c5abe763045aeaa6ef457cf15fbb7

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    workup.STIRRINGstirring
  2. 2
    workup.WAITcontinued at the same temperature for 24 hours
  3. 3
    OtroThe solvent is removed
  4. 4
    Otrothe residue partitioned between ethyl acetate and water
  5. 5
    LavadoThe organic phase is washed with water
  6. 6
    Concentraciónconcentrated
  7. 7
    workup.DISSOLUTIONThe residue is dissolved in isopropanol
  8. 8
    workup.ADDITIONdiluted with iso-hexane forming a precipitate which
  9. 9
    Otrois removed by filtration
  10. 10
    OtroThe mixture is chromatographed (silica
  11. 11
    Lavadoeluting with
  12. 12
    Temperaturaa gradient increasing in polarity from 0 to 50% isopropanol in iso-hexane)

Procedimiento

1-t-Butoxycarbonyl-3-oxopiperazine (21.6 g) is dissolved in dry DMF (500 ml) and potassium t-butoxide (24.2 g) is added. The mixture is stirred at 20-25° for 30 minutes, then 1-(4-methylphenylsulfonyloxy)-2-fluoroethane (J. Med. Chem., 23(9), 985-90 (1980), 25.9 g) is added and stirring continued at the same temperature for 24 hours. The solvent is removed and the residue partitioned between ethyl acetate and water. The organic phase is washed with water and concentrated. The residue is dissolved in isopropanol and diluted with iso-hexane forming a precipitate which is removed by filtration. The mixture is chromatographed (silica; eluting with a gradient increasing in polarity from 0 to 50% isopropanol in iso-hexane) to give 1-t-butoxycarbonyl-4-(2-fluoroethyl)-3-oxopiperazine.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US06613349B2uspto-grants-2003_09